These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9735106)

  • 1. Management of the neck in patients with head and neck cancer treated by concurrent chemotherapy and radiation.
    Weisman RA; Robbins KT
    Otolaryngol Clin North Am; 1998 Oct; 31(5):773-84. PubMed ID: 9735106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM; Prosnitz RG; Hunter S; Fisher SR; Clough RL; Downey MA; Scher RL
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1418-23. PubMed ID: 15050318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
    Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
    Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of salvage neck dissection for advanced regional metastases when induction chemotherapy and radiation are used for organ preservation.
    Wolf GT; Fisher SG
    Laryngoscope; 1992 Aug; 102(8):934-9. PubMed ID: 1495357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer.
    Lavertu P; Adelstein DJ; Saxton JP; Secic M; Wanamaker JR; Eliachar I; Wood BG; Strome M
    Head Neck; 1997 Oct; 19(7):559-66. PubMed ID: 9323143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy in the management of head-and-neck cancer of unknown primary origin: how does the addition of concurrent chemotherapy affect the therapeutic ratio?
    Chen AM; Farwell DG; Lau DH; Li BQ; Luu Q; Donald PJ
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):346-52. PubMed ID: 20933340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer.
    Norris CM; Busse PM; Clark JR
    Semin Surg Oncol; 1993; 9(1):3-13. PubMed ID: 8356382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.
    Roman E; Raez LE; Santos ES
    Expert Rev Anticancer Ther; 2006 Sep; 6(9):1205-15. PubMed ID: 17020455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Planned early neck dissection before radiation for persistent neck nodes after induction chemotherapy.
    Thomas GR; Greenberg J; Wu KT; Moe K; Esclamado R; Bradford C; Carroll W; Eisbruch A; Urba S; Wolf GT
    Laryngoscope; 1997 Aug; 107(8):1129-37. PubMed ID: 9261021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapy pf cervical lymph node metastases of unknown primary tumor].
    Kirschner MJ; Fietkau R; Waldfahrer F; Iro H; Sauer R
    Strahlenther Onkol; 1997 Jul; 173(7):362-8. PubMed ID: 9265258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer.
    Lavertu P; Bonafede JP; Adelstein DJ; Saxton JP; Strome M; Wanamaker JR; Eliachar I; Wood BG
    Arch Otolaryngol Head Neck Surg; 1998 Apr; 124(4):401-6. PubMed ID: 9559686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
    Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
    Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?
    Denaro N; Russi EG; Numico G; Pazzaia T; Vitiello R; Merlano MC
    Oncology; 2013; 84(3):174-85. PubMed ID: 23306430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of planned neck dissection for the N2-N3 neck after chemoradiation for locally advanced squamous cell carcinoma of the head and neck.
    Lau H; Phan T; Mackinnon J; Matthews TW
    Arch Otolaryngol Head Neck Surg; 2008 Mar; 134(3):257-61. PubMed ID: 18347249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on control of N2 and N3 neck disease in squamous cell carcinoma of the head and neck by intra-arterial chemoradiation.
    Weisman RA; Christen RD; Jones VE; Kerber CW; Seagren SL; Orloff LA; Glassmeyer SL; Howell SB; Robbins KT
    Laryngoscope; 1998 Jun; 108(6):800-5. PubMed ID: 9628492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB; Rasch CR; Pameijer FA; Peter E; van den Brekel MW; Tan IB; Schornagel JH; de Bois JA; Zijp LJ; Balm AJ
    Cancer; 2004 Oct; 101(8):1809-17. PubMed ID: 15386309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Planned postradiotherapy neck dissection in patients with advanced head and neck cancer.
    Boyd TS; Harari PM; Tannehill SP; Voytovich MC; Hartig GK; Ford CN; Foote RL; Campbell BH; Schultz CJ
    Head Neck; 1998 Mar; 20(2):132-7. PubMed ID: 9484944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.